Methadone is not prescribed combined with naloxone for opioid use disorder

the verdict

SUPPORTED

the evidence backs this

Recorded sources

4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Methadone is not prescribed combined with naloxone for opioid use disorder?

Yes. Methadone is prescribed as a single-agent opioid agonist for opioid use disorder rather than in combination with naloxone, which is typically combined with buprenorphine or used independently to reverse overdoses.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked 4 Aug 2026

The analysis

The claim states that methadone is not prescribed combined with naloxone for opioid use disorder. The retrieved literature consistently treats methadone as a standalone single-agent medication (often contrasted with buprenorphine/naloxone combinations) and identifies naloxone as either a standalone antagonist or combined specifically with buprenorphine. Therefore, the supporting papers uniformly validate the claim that methadone and naloxone are not combined clinically.

Evidence for · 4

Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose: A Review.

2026

Get citation

MTH, H., ZM, W., & AY, W. (2026). Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose: A Review.. doi.org. https://doi.org/10.1001/jama.2025.26348

See more details

More for · 3

Methadone for Opioid Use Disorder

2020

Get citation

Hand, D. J. (2020). Methadone for Opioid Use Disorder. doi.org. https://doi.org/10.1093/med/9780190920197.003.0008

Differential Impacts of Methadone and Buprenorphine/Naloxone on Pain-Related Outcomes Among People With Non-Heroin Opioid Use Disorder: Secondary Analyses From a Pragmatic Canadian Multisite Trial.

2026

Get citation

K, L., J, C., D, J., B, L. F., S, K., & ME, S. (2026). Differential Impacts of Methadone and Buprenorphine/Naloxone on Pain-Related Outcomes Among People With Non-Heroin Opioid Use Disorder: Secondary Analyses From a Pragmatic Canadian Multisite Trial.. doi.org. https://doi.org/10.1111/dar.70190

The association between the T allele in rs204076 and treatment retention in patients receiving medication for opioid use disorder.

2026

Get citation

A, M., M, R., J, H., DC, M., L, T., & Z, S. (2026). The association between the T allele in rs204076 and treatment retention in patients receiving medication for opioid use disorder.. doi.org. https://doi.org/10.1038/s41598-026-52706-1

Related receipts

Is it true that people who take opioids are at risk for opioid use disorder and overdose? SUPPORTED related question, same topic

What does the evidence say?

Receipt History

first checked04 Aug 2026

judged → SUPPORTED · 7904 Aug 2026

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work